Synapse - Kylee Maclachlan

Results (159)

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Editorial

Holstein, S. A.; Asimakopoulos, F.; Azab, A. K.; Bianchi, G.; Bhutani, M.; Crews, L. A.; Cupedo, T.; Giles, H.; Gooding, S.; Hillengass, J.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Chromothripsis as a pathogenic driver of multiple myeloma

Review

Maura, F.; Boyle, E. M.; Rustad, E. H.; Ashby, C.; Kaminetzky, D.; Bruno, B.; Braunstein, M.; Bauer, M.; Blaney, P.; Wang, Y.; more...
Seminars in Cell and Developmental Biology (2022)

Fulltext@MSK | Save

Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

Journal Article

Boyle, E. M.; Williams, L.; Blaney, P.; Ashby, C.; Bauer, M.; Walker, B. A.; Ghamlouch, H.; Choi, J.; Perrial, E.; Wang, Y.; more...
Leukemia (2022)

Fulltext@MSK | Save

Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures

Meeting Abstract

Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
Blood (2021)

Fulltext@MSK | Save

Molecular evolution of classical Hodgkin lymphoma revealed though whole genome sequencing of Hodgkin and Reed-Sternberg cells

Meeting Abstract

Maura, F.; Imielinski, M.; Xiang, J. Z.; Binder, B.; Eng, K.; Uppal, M.; He, F.; Zhang, W.; Gao, Q.; Park, S. I.; more...
Blood (2021)

Fulltext@MSK | Save

Genomic and immune signatures predict sustained MRD negativity in newly diagnosed multiple myeloma patients treated with daratumumab, carfilzomib, lenalidomide, and dexamethasone (D-KRd)

Meeting Abstract

Maura, F.; Boyle, E. M.; Diamond, B.; Blaney, P.; Ghamlouch, H.; Ziccheddu, B.; Wang, Y.; Maclachlan, K. H.; Hoffman, J. E.; Hassoun, H.; more...
Blood (2021)

Fulltext@MSK | Save

The genomic landscape of Waldenström Macroglobulinemia reveals sustained germinal center activity and late-developing copy number aberrations

Meeting Abstract

Maclachlan, K. H.; Bagratuni, T.; Kastritis, E.; Ziccheddu, B.; Lu, S. X.; Yellapantula, V. D.; Famulare, C.; Diamond, B.; Chojnacka, M.; Raj, A.; more...
Blood (2021)

Fulltext@MSK | Save

Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world experience

Meeting Abstract

Hultcrantz, M.; Orozco, J.; Peterson, T. J.; Derkach, A.; Hassoun, H.; Korde, N.; Lu, S. X.; Mailankody, S.; Patel, D.; Shah, U. A.; more...
Blood (2021)

Fulltext@MSK | Save

Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets

Meeting Abstract

Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
Clinical Lymphoma, Myeloma and Leukemia (2021)

Fulltext@MSK | Save

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

Journal Article

Maclachlan, K. H.; Rustad, E. H.; Derkach, A.; Zheng-Lin, B.; Yellapantula, V.; Diamond, B.; Hultcrantz, M.; Ziccheddu, B.; Boyle, E. M.; Blaney, P.; more...
Nature Communications (2021)

Fulltext@MSK | Save